Short-Term Opioid Withdrawal Using Buprenorphine: Findings and Strategies from a NIDA Clinical Trials Network (CTN) Study

Current Blending Initiative Projects

Short-Term Opioid Withdrawal Using Buprenorphine: Findings and Strategies from a NIDA Clinical Trials Network (CTN) Study

Responsive imageThe Short-term Opioid Withdawal Using Buprenorphine (Bup Detox) Blending Team designed a training package to instruct treatment providers on the administration of aBup Detox Brochure Cover unique,13-day Buprenorphine taper intervention for opioid dependent patients. Research conducted in both inpatient and outpatient settings by the NIDA Clinical Trials Network demonstrated that, in contrast with the clonidine treatment group, patients receiving Buprenorphine provided more opioid-negative urine samples upon completion of the intervention. This training assumes some basic prior information about what Buprenorphine is and how it is used.

 

Buprenorphine Detox Blending Team Members

NIDA/ NDAT CTN

  • Gregory Brigham, Ph.D. - Maryhaven Community Treatment Program
  • Judith Harrer, Ph.D. - VA Medical Center
  • Dennis McCarty, Ph.D. - Oregon Health and Science University

SAMHSA/CSAT-ATTC

  • Thomas Freese, Ph.D. - Pacific Southwest ATTC (Chair)
  • Beth Rutkowski, M.P.H. - Pacific Southwest ATTC
  • Kay Gresham-Morrison, LCSW, ACSW - Southeast ATTC
  • Susan Storti, Ph.D., RN - ATTC of New England

SAMHSA/CSAT Buprenorphine Information Center

Visit Site

This is the site of SAMHSA/CSAT's Buprenorphine Information Center. Included in the site are: general information (e.g., buprenorphine, DATA 2000, Physician and Treatment Program Locator), links to buprenorphine-related reports and publications, and a section specifically for physicians.

Buprenorphine Physician and Treatment Program Locator

Visit Site

The Buprenorphine Physician and Treatment Program Locator is a service of SAMHSA/CSAT. It is an online resource designed to assist States, medical and addiction treatment communities, potential patients, and/or their families in finding information on locating physicians and treatment programs authorized to treat opioid addiction with buprenorphine.